📰 Nasdaq Acgn News
Nasdaq Acgn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Acgn. Real-time updates on events, politics, business and more.
September 26, 2023
Aceragen (NASDAQ:ACGN – Get Free Report) and Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Institutional and Insider Ownership 2.9% of Aceragen shares […]
July 19, 2023
Aceragen, Inc. (NASDAQ:ACGN – Get Free Report) major shareholder Invest Corp Pillar purchased 26,965 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was bought at an average cost of $1.42 per share, with a total value of $38,290.30. Following the completion of the purchase, the insider now […]
May 30, 2023
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”) (Nasdaq: ACGN), announced today that on May 24, 2023, the...
May 20, 2023
Aceragen, Inc. (NASDAQ:ACGN – Get Rating)’s stock price shot up 3.8% during mid-day trading on Wednesday . The stock traded as high as $1.38 and last traded at $1.36. 67,710 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 223,486 shares. The stock had previously closed at $1.31. […]
April 28, 2023
Aceragen, Inc. (NASDAQ:ACGN – Get Rating) shares fell 1.2% on Tuesday . The company traded as low as $1.51 and last traded at $1.65. 19,702 shares were traded during mid-day trading, a decline of 51% from the average session volume of 39,920 shares. The stock had previously closed at $1.67. Aceragen Stock Performance The stock’s […]
April 11, 2023
Aceragen (NASDAQ:ACGN – Get Rating) is one of 283 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Aceragen to related businesses based on the strength of its profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends. Profitability This table compares Aceragen and […]
April 11, 2023
Aceragen (NASDAQ:ACGN – Get Rating) is one of 283 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare Aceragen to related companies based on the strength of its analyst recommendations, risk, earnings, valuation, profitability, institutional ownership and dividends. Valuation and Earnings This table compares […]